ANXA2 regulates the behavior of SGC-7901 cells.

Meng-Yao Sun,Rui-Huan Xing,Xiao-Jie Gao,Xiang Yu,Hui-Min He,Ning Gao,Hong-Yan Shi,Yan-Yan Hu,Qi-Xuan Wang,Jin-Hui Xu,Ying-Chun Hou
DOI: https://doi.org/10.7314/APJCP.2013.14.10.6007
2013-01-01
Asian Pacific Journal of Cancer Prevention
Abstract:ANXA2, a member of the annexin family, is overexpressed and plays important roles in tumor development. However, the significance of ANXA2 expression in gastric carcinoma has not been clarified. To elucidate its roles in growth of gastric cancer, ANXA2 expression in SGC-7901 cells was inhibited with a designated siRNA, then cell proliferation, cell cycling, apoptosis and motility were determined by MTT assay, flow cytometry, Hoechst 33342 staining and wound healing assay, respectively. To further assess the behavior of ANXA2 deleted SGC-7901 cells, changes of microstructures were observed under fluorescence microscopy, laser scanning confocal microscopy and electron microscopy. We found that inhibition of ANXA2 expression caused cell proliferation to decrease significantly with G1 arrest, motility to be reduced with changes in pseudopodia/filopodia structure and F-actin and beta-tubulin expression, and apoptosis to be enhanced albeit without significance. At the same time, ANXA2 deletion resulted in fewer pseudopodia/filopodia, non-stained areas were increased, contact inhibition among cells reappeared, and expression of F-actin and beta-tubulin was decreased, with induction of polymerized disassembled forms. Taken together, these data suggest that ANXA2 overexpression is important to maintain the malignancy of cancer cells, and this member of the annexin family has potential to be considered as a target for the gene therapy of gastric carcinoma.
What problem does this paper attempt to address?